Dr Patrick Monahan, MD | |
110 Luke Ave., Room 405, Afmoa/sgoc, Bolling Afb, DC 20032 | |
(202) 767-4060 | |
Not Available |
Full Name | Dr Patrick Monahan |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 110 Luke Ave., Room 405, Bolling Afb, District Of Columbia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922100270 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 97-319 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Patrick Monahan, MD 1636 Beekman Pl Nw Apt B, Washington, DC 20009-4088 Ph: () - | Dr Patrick Monahan, MD 110 Luke Ave., Room 405, Afmoa/sgoc, Bolling Afb, DC 20032 Ph: (202) 767-4060 |
News Archive
University of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful condition which affects more than two million Australians and costs the country an estimated $23 billion a year.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.
A blood cell known as a troublemaker for triggering the itch and inflammation in allergy attacks, the mast cell, can also calm down the flare-ups, researchers from Stanford University School of Medicine have found.
Exploiting artificial intelligence (AI) to develop tools for improving the monitoring of treatment of rare, progressive, and highly debilitating diseases such as Friedreich's (FRDA) and spinocerebellar ataxia (SCA).
› Verified 5 days ago